108 related articles for article (PubMed ID: 5748206)
1. [Therapeutic study of a new antispasmodic current gynecologic and obstetrical practice].
Harmeau
Gynecol Prat; 1968; 19(1):45-9. PubMed ID: 5748206
[No Abstract] [Full Text] [Related]
2. [Clinical experimentation with a new antispasmodic agent in obstetrics and gynecology: A.118].
Anglade JP; Bertrand J; Monteil R
Therapie; 1971; 26(4):713-22. PubMed ID: 5119124
[No Abstract] [Full Text] [Related]
3. [Usefulness of a new antispasmodic drug, rociverine, in dynamic dystocia].
Pardini I; Maresi MP
Minerva Ginecol; 1980 Sep; 32(9):831-6. PubMed ID: 7219836
[No Abstract] [Full Text] [Related]
4. [Treatment of functional cervical dystokia].
Magnin P; Chabert LM
Rev Fr Gynecol Obstet; 1965 May; 60(5):375-93. PubMed ID: 5833284
[No Abstract] [Full Text] [Related]
5. [Trial of an injectable antispasmodic agent, Dilavacol, during delivery (apropos of 50 cases)].
Anglade JP; Monteil L; Cherasse A
Therapie; 1971; 26(3):431-8. PubMed ID: 5165406
[No Abstract] [Full Text] [Related]
6. [Value of the rapid perfusion of Spasfon in high doses in dynamic dystocia and anomalies of dilatation].
Hourcabie J; Ambonville C; Albalat F; Becat A
J Gynecol Obstet Biol Reprod (Paris); 1976 Sep; 5(6):847-8. PubMed ID: 1026765
[No Abstract] [Full Text] [Related]
7. [The diethylaminoethylamide of the monoethylic ester of phenylethylmalonic acid in the treatment of dynamic dystocias of the dilating period].
Aluigi A
Attual Ostet Ginecol; 1966; 12(5):699-714. PubMed ID: 6011543
[No Abstract] [Full Text] [Related]
8. [Inhibition of uterine contractability in dystocia (author's transl)].
Bárdos A
Cesk Gynekol; 1973 Nov; 38(9):675-6. PubMed ID: 4765164
[No Abstract] [Full Text] [Related]
9. [Effects of proxazole on spastic dystocia of the uterine cervix].
Polacco V; Piccolomini A; Masin G; Scivoli L; Suma V
Riv Ital Ginecol; 1977; 58(1-2):71-80. PubMed ID: 617874
[No Abstract] [Full Text] [Related]
10. [Use of oxybutynin hydrochloride in the treatment of primary dysmenorrhea].
Piato S; Delascio D
Matern Infanc (Sao Paulo); 1968; 27(2):95-101. PubMed ID: 5746834
[No Abstract] [Full Text] [Related]
11. [Treatment of functional dysmenorrhea with RO 4-6161].
Branger F
Praxis; 1966 Sep; 55(38):1083-7. PubMed ID: 6013411
[No Abstract] [Full Text] [Related]
12. [Study of the action of the association of glyceric ether of guaiacol and camylofine on the dilatation of the cervix during the labor].
Auclair JM; Anton JP; Bellocq J; Zylberberg B
Rev Fr Gynecol Obstet; 1970 Sep; 65(9):523-8. PubMed ID: 5466471
[No Abstract] [Full Text] [Related]
13. [Clinical and experimental results of the use of a synthetic spasmolytic drug (Phenalamide) in the medical induction of labor and in directed labor, in hypertonic dystocias and in cervical dystocias].
De Marini M
Quad Clin Ostet Ginecol; 1967 Dec; 22(12):920-30. PubMed ID: 5630260
[No Abstract] [Full Text] [Related]
14. [Utilization in current obstetrical practice of utero-relaxant, preserving alertness].
Bertrand P; Humruzian J
Rev Fr Gynecol Obstet; 1969; 64(7):427-33. PubMed ID: 5385875
[No Abstract] [Full Text] [Related]
15. [Use of palerol in the treatment of painful menstruation in puberty].
Cieciorowska A
Pol Tyg Lek; 1965 May; 20(18):644-6. PubMed ID: 5838840
[No Abstract] [Full Text] [Related]
16. [Clinical experiences with a new spasmolytic, Rowapraxin].
Chlud K
Med Welt; 1969 Aug; 33():1801-3. PubMed ID: 5357983
[No Abstract] [Full Text] [Related]
17. [Value of the use of gamma OH in the course of labor in cervicosegmental dystocia].
Casalta E; Zwirn H
Anesth Analg (Paris); 1965; 22(2):299-301. PubMed ID: 5890715
[No Abstract] [Full Text] [Related]
18. [Menstrual complaints. Etiology and therapy].
Bosse-Bringewatt K
Med Monatsschr Pharm; 1997 Jan; 20(1):9-16. PubMed ID: 9082157
[No Abstract] [Full Text] [Related]
19. [On the therapeutic use of estrogen-gestagen-combination (AK 103) in gynecologic practice].
Schmör J
Wien Klin Wochenschr; 1966 Apr; 78(13):230-2. PubMed ID: 5983528
[No Abstract] [Full Text] [Related]
20. [Value of a new combined antispasmodic-antalgic in current medical practice].
Galley P
Therapeutique; 1969 Dec; 45(10):1021-4. PubMed ID: 5396160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
